Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.34 |
| ▸ | GRIN1 | Q05586 | 6/20 | 0.32 |
| ▸ | GRIN2B | Q13224 | 6/20 | 0.32 |
| ▸ | MTOR | P42345 | 1/20 | 0.31 |
| ▸ | SLC9A1 | P19634 | 2/20 | 0.31 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26549302 | 0.94 | ALOX5 (0.37) | ALOX5GRIN1GRIN2BMTORSLC9A1 | |
| SCHEMBL26549298 | 0.89 | ALOX5 (0.38) | ALOX5MTORSLC9A1 | |
| SCHEMBL26548322 | 0.87 | ALOX5 (0.40) | ALOX5SLC9A1 | |
| SCHEMBL26559751 | 0.87 | ALOX5 (0.36) | ALOX5SLC9A1 | |
| SCHEMBL26548821 | 0.86 | ALOX5 (0.40) | ALOX5SLC9A1 | |
| SCHEMBL26569704 | 0.86 | ALOX5 (0.40) | ALOX5 | |
| SCHEMBL26549430 | 0.85 | ALOX5 (0.41) | ALOX5GRIN1GRIN2BMTORSLC9A1 | |
| SCHEMBL26549152 | 0.85 | ALOX5 (0.41) | ALOX5GRIN1GRIN2BMTORSLC9A1 | |
| SCHEMBL26549296 | 0.82 | ALOX5 (0.40) | ALOX5MTORSLC9A1 | |
| SCHEMBL26548314 | 0.82 | ALOX5 (0.41) | ALOX5ENPP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230337527-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | LAPTO CO., LTD. (KR) | 2023-10-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230337527-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | AOC1, ODC1, PIEZO1 | ALOX5 1577/4885GRIN1 957/4885GRIN2B 2102/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.